4.5 Review

Mechanisms of transcriptional regulation by WT1 (Wilms' tumour 1)

Journal

BIOCHEMICAL JOURNAL
Volume 461, Issue -, Pages 15-32

Publisher

PORTLAND PRESS LTD
DOI: 10.1042/BJ20131587

Keywords

co-activator; co-repressor; promoter; transcription; Wilms' tumour 1 (WT1); zinc finger

Funding

  1. NIGMS NIH HHS [R01 GM098609] Funding Source: Medline

Ask authors/readers for more resources

The WT1 (Wilms' tumour 1) gene encodes a zinc finger transcription factor and RNA-binding protein that direct the development of several organs and tissues. WT1 manifests both tumour suppressor and oncogenic activities, but the reasons behind these opposing functions are still not clear. As a transcriptional regulator, WT1 can either activate or repress numerous target genes resulting in disparate biological effects such as growth, differentiation and apoptosis. The complex nature of WT1 is exemplified by a plethora of isoforms, post-translational modifications and multiple binding partners. How WT1 achieves specificity to regulate a large number of target genes involved in diverse physiological processes is the focus of the present review. We discuss the Wealth of the growing molecular information that defines our current understanding of the versatility and utility of WT1 as a master regulator of organ development, a tumour suppressor and an oncogene.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Correction Oncology

Overview of the relevance of PI3K pathway in HR-positive breast cancer (vol 30, pg 3, 2019)

N. Vasan, E. Toska, M. Scaltriti

ANNALS OF ONCOLOGY (2020)

Article Genetics & Heredity

ARID1A determines luminal identity and therapeutic response in estrogen-receptor-positive breast cancer

Guotai Xu, Sagar Chhangawala, Emiliano Cocco, Pedram Razavi, Yanyan Cai, Jordan E. Otto, Lorenzo Ferrando, Pier Selenica, Erik Ladewig, Carmen Chan, Arnaud Da Cruz Paula, Matthew Witkin, Yuanming Cheng, Jane Park, Cristian Serna-Tamayo, HuiYong Zhao, Fan Wu, Mirna Sallaku, Xuan Qu, Alison Zhao, Clayton K. Collings, Andrew R. D'Avino, Komal Jhaveri, Richard Koche, Ross L. Levine, Jorge S. Reis-Filho, Cigall Kadoch, Maurizio Scaltriti, Christina S. Leslie, Jose Baselga, Eneda Toska

NATURE GENETICS (2020)

Article Endocrinology & Metabolism

Differential Effects of Diet and Weight on Taste Responses in Diet-Induced Obese Mice

Zachary C. Ahart, Laura E. Martin, Bailey R. Kemp, Debarghya Dutta Banik, Stefan G. E. Roberts, Ann-Marie Torregrossa, Kathryn F. Medler

OBESITY (2020)

Article Oncology

Selective Inhibition of HDAC3 Targets Synthetic Vulnerabilities and Activates Immune Surveillance in Lymphoma

Patrizia Mondello, Saber Tadros, Matt Teater, Lorena Fontan, Aaron Y. Chang, Neeraj Jain, Haopeng Yang, Shailbala Singh, Hsia-Yuan Ying, Chi-Shuen Chu, Man Chun John Ma, Eneda Toska, Stefan Alig, Matthew Durant, Elisa de Stanchina, Sreejoyee Ghosh, Anja Mottok, Loretta Nastoupil, Sattva S. Neelapu, Oliver Weigert, Giorgio Inghirami, Jose Baselga, Anas Younes, Cassian Yee, Ahmet Dogan, David A. Scheinberg, Robert G. Roeder, Ari M. Melnick, Michael R. Green

CANCER DISCOVERY (2020)

Article Oncology

FOXA1 Mutations Reveal Distinct Chromatin Profiles and Influence Therapeutic Response in Breast Cancer

Amaia Arruabarrena-Aristorena, Jesper L. V. Maag, Srushti Kittane, Yanyan Cai, Wouter R. Karthaus, Erik Ladewig, Jane Park, Srinivasaraghavan Kannan, Lorenzo Ferrando, Emiliano Cocco, Sik Y. Ho, Daisylyn S. Tan, Mirna Sallaku, Fan Wu, Barbara Acevedo, Pier Selenica, Dara S. Ross, Matthew Witkin, Charles L. Sawyers, Jorge S. Reis-Filho, Chandra S. Verma, Ralf Jauch, Richard Koche, Jose Baselga, Pedram Razavi, Eneda Toska, Maurizio Scaltriti

CANCER CELL (2020)

Article Biochemistry & Molecular Biology

WT1 activates transcription of the splice factor kinase SRPK1 gene in PC3 and K562 cancer cells in the absence of corepressor BASP1

Tareg Belali, Chigeru Wodi, Bethany Clark, Man-Kim Cheung, Tim J. Craig, Gabrielle Wheway, Nicole Wagner, Kay-Dietrich Wagner, Stefan Roberts, Sean Porazinski, Michael Ladomery

BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2020)

Article Multidisciplinary Sciences

Cholesterol is required for transcriptional repression by BASP1

Amy E. Loats, Samantha Carrera, Anna F. Fleming, Abigail R. E. Roberts, Alice Sherrard, Eneda Toska, Alexander J. Moorhouse, Kathryn F. Medler, Stefan G. E. Roberts

Summary: The study reveals that the lipidated protein BASP1 recruits cholesterol to the promoter region of target genes in the cell nucleus through a conserved interaction motif, and that BASP1's interaction with cholesterol is required for chromatin remodeling and the direction of transcription programs controlling cell differentiation.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Article Multidisciplinary Sciences

UDP-glucose pyrophosphorylase 2, a regulator of glycogen synthesis and glycosylation, is critical for pancreatic cancer growth

Andrew L. Wolfe, Qingwen Zhou, Eneda Toska, Jacqueline Galeas, Angel A. Ku, Richard P. Koche, Sourav Bandyopadhyay, Maurizio Scaltriti, Carlito B. Lebrilla, Frank McCormick, Sung Eun Kim

Summary: The enzyme UGP2, which synthesizes UDP-glucose, plays a crucial role in maintaining pancreatic ductal adenocarcinoma (PDAC) growth. Its transcription is directly regulated by the YAP-TEAD complex, and loss of UGP2 leads to decreased glycogen levels and defects in glycosylation of important targets for PDAC survival.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Letter Hematology

Crosstalk between β-catenin and WT1 signaling activity in acute myeloid leukemia

Megan Wagstaff, Olga Tsaponina, Gilian Caalim, Hayley Greenfield, Leanne Milton-Harris, Erika J. Mancini, Allison Blair, Kate J. Heesom, Alex Tonks, Richard L. Darley, Stefan G. Roberts, Rhys G. Morgan

HAEMATOLOGICA (2023)

Article Multidisciplinary Sciences

The BASP1 transcriptional corepressor modifies chromatin through lipid-dependent and lipid-independent mechanisms

Alexander J. Moorhouse, Amy E. Loats, Kathryn F. Medler, Stefan G. E. Roberts

Summary: The transcriptional corepressor BASP1 requires N-terminal myristoylation for its activity and functions through interactions with nuclear lipids. Removal of active histone modifications H3K9ac and H3K4me3 by BASP1 requires N-terminal myristoylation, while placement of the repressive histone modification H3K27me3 does not require lipidation. BASP1 regulates activity of multiple transcription factors and induces extensive changes in chromatin accessibility, with about 50% of BASP1 target genes showing lipidation-dependent chromatin compaction and transcriptional repression.

ISCIENCE (2022)

Editorial Material Oncology

A Unique FOXA1-Associated Chromatin State Dictates Therapeutic Resistance in Lobular Breast Cancer

Ryan Blawski, Eneda Toska

Summary: In this study, the authors investigated the mechanisms of differential therapy response in invasive lobular carcinomas (ILC) compared to invasive ductal carcinomas (IDC). They found an alternative chromatin accessibility state in ILC driven by the pioneer factor FOXA1, which promotes the transcription of genes associated with tumor progression and tamoxifen resistance. Targeting the FOXA1 enhancer region blocks this transcriptional program and inhibits ILC proliferation.

CANCER RESEARCH (2022)

Article Oncology

BASP1 down-regulates RANKL-induced osteoclastogenesis

Anuj Anuj, Nina Reuven, Stefan G. E. Roberts, Ari Elson

Summary: The cytokine RANKL is involved in the differentiation of monocytes/macrophages into bone-resorbing osteoclasts, and it down-regulates the expression of BASP1 which is a negative regulator of osteoclastogenesis. Knocking down or eliminating BASP1 enhances RANKL-induced osteoclastogenesis, promoting cell-cell fusion and increasing mineral degrading abilities of osteoclasts.

EXPERIMENTAL CELL RESEARCH (2023)

Meeting Abstract Oncology

Double PIK3CA mutations in cis enhance oncogene activation and sensitivity to PI3K alpha inhibitors in breast cancer

Neil Vasan, Pedram Razavi, Jared Johnson, Hong Shao, Hardik Shah, Alesia Antoine, Erik Ladewig, Alexander Gorelick, Eneda Toska, Guotai Xu, Abiha Kazmi, Matthew T. Chang, Barry S. Taylor, Maura N. Dickler, Komal Jhaveri, Raul Rabadan, Ed Reznik, Melissa L. Smith, Robert Sebra, Lewis C. Cantley, Maurizio Scaltriti, Jose Baselga

CANCER RESEARCH (2019)

Meeting Abstract Oncology

PI3K pathway mediated splicing defects in ER plus breast cancers

Erik Ladewig, Lauren Fairchild, Maurizio Scaltriti, Christina Leslie, Eneda Toska, Jose Baselga

CANCER RESEARCH (2019)

Article Biology

The WT1-BASP1 complex is required to maintain the differentiated state of taste receptor cells

Yankun Gao, Debarghya Dutta Banik, Mutia M. Muna, Stefan G. E. Roberts, Kathryn F. Medler

LIFE SCIENCE ALLIANCE (2019)

No Data Available